Sanus Nexus - Company finances
|
EUR
|
2023
From: 2023-01-17
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|
|
Financial data
|
|||
| Sales revenue | 1,103,702 | 2,943,697 | 3,985,803 |
| Profit before tax | -564 | 119,706 | 143,676 |
| Net profit | -588 | 101,260 | 119,785 |
| Equity | 1,912 | 103,172 | 209,760 |
| Liabilities | 519,064 | 647,737 | 750,463 |
| Non-current assets | 1,136 | 9,345 | 8,326 |
| Current assets | 521,731 | 740,915 | 951,846 |
| Total assets | 522,867 | 750,260 | 960,172 |
|
Taxes paid
|
|||
| Social insurance contributions | - | - | 16,447 |
|
Financial indicators
|
|||
| Revenue change y/y | - | +166.7% | +35.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -0.1% | 13.5% | 12.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -30.8% | 98.1% | 57.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -0.1% | 3.4% | 3.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -0.1% | 4.1% | 3.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 271.5 | 6.3 | 3.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 827,797 | 1,070,435 | 1,112,327 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sanus Nexus - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-08-28 | 2025-08-29 | 210.99 |
| 2025-08-19 | 2025-08-21 | 210.99 |
| 2025-04-24 | 2025-04-29 | 4.99 |
| 2025-02-10 | 2025-02-10 | 1231.66 |
| 2025-01-16 | 2025-01-29 | 1231.66 |
| 2024-08-19 | 2024-08-19 | 192.38 |
| 2024-07-29 | 2024-08-07 | 0.67 |
| 2024-07-25 | 2024-07-25 | 0.67 |
| 2024-07-24 | 2024-07-24 | 192.38 |
| 2024-07-16 | 2024-07-23 | 191.71 |
| 2024-06-18 | 2024-07-07 | 3.98 |
| 2024-05-16 | 2024-05-26 | 187.06 |
| 2023-12-18 | 2024-01-03 | 0.46 |
| 2023-11-16 | 2023-11-30 | 0.46 |
| 2023-10-25 | 2023-11-02 | 0.46 |
| 2023-07-18 | 2023-07-20 | 397.64 |
Sanus Nexus - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-06-26 | 4.74 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sanus Nexus, UAB, a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods, posted a strong 2025 result. Revenue reached €3.99M in the latest financial year 2025, up 35.4% year on year and 261.1% over two years. Net profit increased to €119.8K, while the profit margin remained moderate at 3.0%. The company’s trajectory shows a clear turnaround from a small loss in 2023, when revenue was €1.10M and net profit was -€588, to profitability in 2024 with €2.94M revenue and €101.3K net profit, followed by further growth in 2025. At year-end 2025, total assets stood at €960.2K, supported by equity of €209.8K and liabilities of €750.5K. The equity ratio was 21.9%, and debt-to-equity stood at 3.58. Asset turnover was 4.15x, indicating efficient use of the asset base. Based on staff data, revenue per employee was €1.33M and profit per employee €39.9K, pointing to high productivity in the latest year.